Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by GunnerGon Dec 21, 2019 1:13pm
125 Views
Post# 30479837

Not visions of sugar plums Pando

Not visions of sugar plums Pandoread slooowly.  Production employee reduction 20% (not replacing execs) but production employees; just before the big push.  Also, top two scientists, instumental in Ryp and 4050 have been let go..

I chuckle at your statement that TV setting objectives.  Not much has changes with respect to so called commercial products.  Still stuck where we have been for two years,  even with "new management" at the helm for over a year now.

Your such a doofus pando number five.
<< Previous
Bullboard Posts
Next >>